apollo
0
  1. Home
  2. Medicine
  3. Biomab Egfr 50 mg Injection 1's

Written By Santoshini Reddy G , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
Non returnable*
COD available

Online payment accepted

rxMedicinePrescription drug

Whats That

tooltip

Composition :

NIMOTUZUMAB-50MG

Manufacturer/Marketer :

Biocon Ltd

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

Expires on or after :

About Biomab Egfr 50 mg Injection

Biomab Egfr 50 mg Injection belongs to the group of anti-cancer medicines used to treat head and neck cancer with concurrent chemotherapy and/or radiotherapy. It may also be indicated in the treatment of glioma (growth of tumours in the brain or spinal cord) and nasopharyngeal cancer.
 
Biomab Egfr 50 mg Injection contains Nimotuzumab, a recombinant humanised monoclonal antibody that works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer.
 
In some cases, Biomab Egfr 50 mg Injection may cause side effects like fever, chills, headache, itching, and mucositis. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.
 
Do not use Biomab Egfr 50 mg Injection if you are allergic to any of its components. Consult the doctor if you are pregnant or breastfeeding. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.

Uses of Biomab Egfr 50 mg Injection

Head and neck cancer

Directions for Use

Biomab Egfr 50 mg Injection will be administered by a healthcare professional; do not self-administer.

Medicinal Benefits

Biomab Egfr 50 mg Injection belongs to the group of anti-cancer medicines used to treat head and neck cancer with concurrent chemotherapy and/or radiotherapy. Biomab Egfr 50 mg Injection contains Nimotuzumab, a recombinant humanised monoclonal antibody that works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer. Nimotuzumab may also be indicated in the treatment of glioma (growth of tumours in the brain or spinal cord) and nasopharyngeal cancer.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

Do not use Biomab Egfr 50 mg Injection if you are allergic to any of its components. Inform the doctor if you are pregnant or breastfeeding. Please consult the doctor if you have any concerns regarding the usage of Biomab Egfr 50 mg Injection in children. Let the doctor know if you have any health conditions or if you are taking any medications, including herbal supplements.

Diet & Lifestyle Advise

  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Avoid smoking and alcohol consumption.
  • Include vegetables and fruits in your diet.
  • Avoid fast food, fried food, processed meats, refined carbs and added sugar.
  • Get optimal sleep; rest well.

Habit Forming

No

Therapeutic Class

CHEMOTHERAPY

FAQs

Biomab Egfr 50 mg Injection works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer.

Biomab Egfr 50 mg Injection may cause hypertension (high blood pressure) and fluctuation in blood pressure. Consult the doctor if you have high blood pressure or if you experience fluctuation in blood pressure.

Mucositis (swelling and irritation of mucosa) could be a side effect of Biomab Egfr 50 mg Injection. If the condition persists or worsens, consult the doctor.

Disease/Condition Glossary

Head and neck cancer: Head and neck cancer includes cancer in the throat, larynx, nose, lips, mouth, and salivary glands. The risk of head and neck cancer increases with heavy alcohol use, tobacco use, and infection with human papillomavirus (HPV). Symptoms include persistent sore throat, changes in voice, trouble swallowing, and a sore or lump that does not heal.

Have a query?

0
whatsapp Floating Button
Buy Now
Add to Cart